Sun Pharma ne market se **₹7,816 Crore** ka fund raise kiya hai. Company ne ye paisa **5 saal** ki maturity waale two-part bonds ke zariye jutaya hai, taaki apne expansion aur specialty drugs ke kaam ko speed di ja sake.
Badi fundraising aur strategy
Sun Pharma ne domestic debt market se ₹7,816 Crore ka bada amount raise kiya hai. Ye pura process dual-tranche bond issuance ke zariye hua hai, jo company ki strong credit profile ko dikhata hai. Inhe CRISIL aur ICRA jaisi top agencies se solid ratings mili hui hain.
Bonds ka breakdown aur interest rates
Fundraising ko do parts mein baanta gaya hai, dono ka tenure 5 saal aur 1 din hai:
- Tranche 1: Isme ₹2,003 Crore raise kiye gaye hain, jiska interest rate (coupon) 8.05% hai. Isme ek khaas feature hai jahan investors 17 mahine baad repayment maang sakte hain.
- Tranche 2: Ye bada hissa hai jisme ₹5,813 Crore jama kiye gaye hain, iska coupon rate 8.20% hai.
Investors ke liye kya matlab hai?
Company bank loans ki jagah bonds par focus kar rahi hai taaki apne balance sheet ko optimize kar sake. Halanki exact usage reveal nahi hua hai, par ye paisa R&D, nayi capacity building aur specialty medicines ke expansion mein kaam aayega. Pharma sector mein competition tagda hai, isliye ab sabki nazar is baat par hogi ki ye investment long-term mein profitability kaise badhati hai. Debt lena sahi hai, par cash generation consistency check karna zaroori hai.